Sol-Gel Technologies

SLGL • NASDAQ • Stock Fundamentals

Sol-Gel Technologies is a biotechnology company in the healthcare sector trading on NASDAQ, led by CEO Moshe Arkin, with a market cap of $241.8M.

Market Cap$241.8M

Employees36.0

CEOMoshe Arkin

CountryIsrael

Healthcare

Biotechnology

Most Recent EarningsMar 19, 2026 · 2 months 9 days agoQ4 2025

Next EarningsAug 6, 2026 · in 2 monthsBefore Market Open · Q2 2026

Financials

Based on Q4 2025 filing

Common questions about Sol-Gel Technologies

Sol-Gel Technologies (SLGL) has a market capitalization of $241.8M and trades on NASDAQ.

Sol-Gel Technologies has approximately 36 employees.